Assesment Of The Efficacy Of HESA-A On The Proliferation And Apoptosis Of Chronic Myelogenous Leukemia Cell Line(K562)

Assesment Of The Efficacy Of HESA-A On The Proliferation And Apoptosis Of Chronic Myelogenous Leukemia Cell Line(K562)

Show other versions (1)

Background and Aim: Chronic myelogenous leukemia is characterized by Philadelphia (Ph) chromosome, the presence of BCR-ABL fusion gene and constitutive activation of the ABL1 tyrosine kinase. Despite an excellent result of target therapy by imatinib, some patients develop resistance to imatinib. In...

Full description

Bibliographic Details
Main Authors:	Mahdihe Ghasemi, Fatemeh Nadali, Seyed Naser Ostad, Farhad Zaker, Shahrbanoo Rostamy, Hossein Dargahi
Format:	Article
Language:	fas
Published:	Tehran University of Medical Sciences 2012-12-01
Series:	پیاورد سلامت
Subjects:	Chronic Myelogenous Leukemia HESA-A Cytotoxicity Apoptosis
Online Access:	http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/22749.pdf&manuscript_id=22749

Similar Items

Assesment Of The Efficacy Of HESA-A On The Proliferation And Apoptosis Of Chronic Myelogenous Leukemia Cell Line(K562)
by: Mahdihe Ghasemi, et al.
Published: (2012-11-01)

Effect Of HESA-A On Acute Promyelocytic Cell Line(NB4)
by: Soodeh Namjoo, et al.
Published: (2012-09-01)

Assessment of Selective Growth Inhibitory Effects of HESA-A on Some Human Neoplastic Cell Lines
by: Samad Muhammmadnejad, et al.
Published: (2014-04-01)

Acute appendicitis revealing a diagnosis of chronic myelogenous leukemia
by: Rita Ahmad, et al.
Published: (2021-04-01)

Acute Myelogenous Leukemia Mimicking Fulminant Periorbital Cellulitis
by: Abbas Bagheri, et al.
Published: (2013-01-01)

Wnt Signaling Pathway and Chronic Myelogenous Leukemia
by: HOU Yan, et al.
Published: (2019-02-01)

Targeting the Process of c-MYC Stabilization in Chronic Myelogenous Leukemia
by: Sunohara, Maxwell
Published: (2017)

Therapeutic effects of HESA-A (a herbal-marine compound) in acute organophosphorus pesticide poisoning
by: Seyed Reza Mousavi, et al.
Published: (2020-05-01)

HESA-A Exerts Its Cytoprotective Effects through Scavenging of Free Radicals: An in Vitro Study
by: Mehryar Habibi Roudkenar, et al.
Published: (2012-03-01)

Suppression of hesA mutation on nitrogenase activity in Paenibacillus polymyxa WLY78 with the addition of high levels of molybdate or cystine
by: Xiaomeng Liu, et al.
Published: (2019-02-01)

Acute myelogenous leukemia revealed by acute appendicitis
by: Sanae El Marzguioui, et al.
Published: (2020-01-01)

Dasatinib-Induced Colitis in a Patient with Chronic Myelogenous Leukemia
by: David N. Perdigoto, et al.
Published: (2017-10-01)

TREATMENT WITH IMATINIB MESILAT IN CHRONIC MYELOGENOUS LEUKEMIA – OUR EXPERIENCE
by: Mateja Grat, et al.
Published: (2004-12-01)

Determination of SFRP1 and SFRP2 Genes Promoter Methylation Status in Patients with Chronic Myelogenous Leukemia
by: Elahe Derakhshanfar, et al.
Published: (2017-03-01)

Bilineage T-lymphoblastic/myeloid extramedullary blast crisis in chronic myelogenous leukemia
by: Indu M Nair, et al.
Published: (2016-01-01)

In vitro cytotoxicity of the LDE: daunorubicin complex in acute myelogenous leukemia blast cells
by: P.E. Dorlhiac-Llacer, et al.
Published: (2001-10-01)

Chronic myelogenous leukemia in sickle cell/beta 0 -thalassemia
by: Maha M Sallam, et al.
Published: (2011-01-01)

Evaluation of the Effect of Two Systemic Doses of HESA-A on Prevention of Induced Tongue Neoplasm in Rats
by: Masoumeh Mehdipour, et al.
Published: (2013-12-01)

Platelet Microparticles Protect Acute Myelogenous Leukemia Cells against Daunorubicin-Induced Apoptosis
by: Daniel Cacic, et al.
Published: (2021-04-01)

Bilateral Serous Macular Detachment in Acute Myelogenous Leukemia
by: Müge Karataş, et al.
Published: (2014-03-01)

Aurora kinase inhibitors: which role in the treatment of chronic myelogenous leukemia patients resistant to imatinib?
by: Giovanni Martinelli, et al.
Published: (2009-02-01)

Imatinib Therapy in Chronic Myelogenous Leukemia and Thyroid Function Tests
by: Mohammad Ali Mashhadi, et al.
Published: (2014-09-01)

Initial presentation of acute myelogenous leukemia in the infiltrate underlying an actinic keratosis
by: Collin Blattner, et al.
Published: (2014-01-01)

Update on the management of Philadelphia chromosome positive chronic myelogenous leukemia: role of nilotinib
by: Emole J, et al.
Published: (2016-02-01)

Kidney Failure and Abdominal Discomfort as Initial Signs of Extramedullary Acute Myelogenous Leukemia
by: Peter Ferkis Steinfeld, et al.
Published: (2021-07-01)

Indefinite Azacitidine Treatment Until Progression May Provide Long-Term Disease Control in Elderly Patients with Acute Myelogenous Leukemia
by: Ali ESER, et al.
Published: (2018-07-01)

"HLA Class II Allele and Haplotype Frequencies in Iranian Patients with Acute Myelogenous Leukemia and Control Group "
by: Abdolfattah Sarafnejad, et al.
Published: (2006-09-01)

Chronic myelogenous leukemia on target
by: Veronika Némethová, et al.
Published: (2018-07-01)

Molecular response in long-term monitoring of patients with chronic myelogenic leukemia (CML) on nilotinib therapy
by: Dragomira Nikolova, et al.
Published: (2021-01-01)

Integrative Analysis of Multi-Omics Identified the Prognostic Biomarkers in Acute Myelogenous Leukemia
by: Jiafeng Zheng, et al.
Published: (2020-12-01)

Protective autophagy or autophagic death: effects of BEZ235 on chronic myelogenous leukemia
by: Xin P, et al.
Published: (2019-08-01)

The treatment of pediatric chronic myelogenous leukemia in the imatinib era
by: Jae Wook Lee, et al.
Published: (2011-03-01)

Isolation of Mycobacterium branderi, an unusual species from an acute myelogenous leukemia patient
by: Majid Marjani, et al.
Published: (2014-01-01)

Rhabdomyolysis Associated with Fenofibrate Monotherapy in a Patient with Chronic Myelogenous Leukemia
by: Kazuya Kato, et al.
Published: (2011-08-01)

Efficacy of imatinib mesylate-based front-line therapy in pediatric chronic myelogenous leukemia
by: Hyun Jin Oh, et al.
Published: (2013-08-01)

Cytotoxic effect of Spirulina platensis extracts on human acute leukemia Kasumi-1 and chronic myelogenous leukemia K-562 cell lines
by: Flor Yohana Flores Hernandez, et al.
Published: (2017-01-01)

Renal Bleeding Due to Extramedullary Hematopoiesis in a Patient With Chronic Myelogenous Leukemia
by: Stephanie Zettner, et al.
Published: (2014-11-01)

Applications of Microarray Technology to Acute Myelogenous Leukemia
by: Rashmi S. Goswami, et al.
Published: (2009-01-01)

HLA Class II Allele and Haplotype Frequencies in Iranian Patients with Leukemia
by: Farideh Khosravi, et al.
Published: (2007-09-01)

Chronic lymphocytic leukemia developing in a case of chronic myelogenous leukemia - accelerated phase: A rare case with review of the literature
by: Narender Kumar, et al.
Published: (2013-01-01)

Cannot write session to /tmp/vufind_sessions/sess_up4qpuaovgppsjvbum4775klg5